METTL3 and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC), METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis, leading to drug resistance and metastasis [13].